Mankind Pharma forays into the Agri-tech industry

New Delhi : Mankind Pharma has announced the launch of Mankind Agritech Pvt Ltd. The company has entered into the ever-growing Indian agri-Input segment to use technological innovations in the field and bring its expertise to Indian farmlands and the Indian agriculture consumers, respectively. The decision behind foraying into this division is to assist Indian farmers by providing new-age technologies and helping farmers for the betterment of the rural sector.

With the launch of Mankind Agritech, the company will be providing crop care solutions to Indian farmers, including weedicides, insecticides, fungicides, plant growth regulators and biologicals. Mankind Agritech will work towards food safety for the country . The company will invest in the new technological tools and aims to deliver the same to the farmers to support them.

Announcing the launch ,Mr Rajeev Juneja, Managing Director and Vice-Chairman, Mankind Pharma said, “We are happy to announce our launch in the Agritech domain with long-term investment plans with an initial 150 to 200 crore Capex infusion in the first two to three years. Mankind Agritech is committed to bring world-class crop protection technology to Indian farmers. Technology is playing a crucial role in ensuring the growth of the agriculture sector in India. Agritech has the potential to scale up the agricultural industry through technological intervention. If the farmers get the right products and tools they would be in a position to make an informed decision of using input and right technology. Mankind Agritech will ensure quality assurance to the farmers.

The new vertical will be headed by Mr Partha Sengupta, a veteran of the Indian agrochemical industry. Mr Partha Sengupta brings in a plethora of experience from the agrochemical industry with over three decades of experience in Sales and Marketing. Mr Sengupta was National Marketing Head and part of the Senior Leadership team at Dhanuka Agritech Limited overseeing Marketing operations in India, Bangladesh, and Nepal.

  • Related Posts

    HP HC quashes CDSCO complaints against pharma firms over jurisdictional and procedural lapses

    In a landmark ruling that will have far-reaching implications for the pharmaceutical sector, the High Court of Himachal Pradesh has quashed three criminal complaints filed by the Central Drugs Standard…

    Eli Lilly launches cancer drug Tanstrive in India

    New Delhi: Eli Lilly and Company India on Thursday announced the launch of its cancer treatment drug Tanstrive in India. The launch follows marketing authorisation from the Central Drugs Standard Control Organisation…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    HP HC quashes CDSCO complaints against pharma firms over jurisdictional and procedural lapses

    HP HC quashes CDSCO complaints against pharma firms over jurisdictional and procedural lapses

    Eli Lilly launches cancer drug Tanstrive in India

    Eli Lilly launches cancer drug Tanstrive in India

    Sir Ganga Ram Hospital excels in Medical Research among Private Hospitals

    Sir Ganga Ram Hospital excels in Medical Research among Private Hospitals

    Centre eases BIS quality compliance with new risk-based framework for manufacturers

    Centre eases BIS quality compliance with new risk-based framework for manufacturers

    SS Innovations International aces Race beating Global Giants in Surgical Robotics

    SS Innovations International aces Race beating Global Giants in Surgical Robotics

    ‘SHE’ comes all the Way from Calcutta to Delhi to Care for Women’s Fertility

    ‘SHE’ comes all the Way from Calcutta to Delhi to Care for Women’s Fertility